Cargando…

Evaluation of latent tuberculosis infection in liver transplant recipients

BACKGROUND AND OBJECTIVES: Tuberculosis is one of the main reasons for mortality in liver transplant recipients. Since Iran is considered as a tuberculosis-endemic country, the present study aims to evaluate the outcome of latent tuberculosis infection in transplant recipients after liver transplant...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadinejad, Zahra, Mokhtaryan, Maryam, Salami, Arezoo, Talebian, Monavar, Irajian, Hamideh, Ghiasvand, Fereshteh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408033/
https://www.ncbi.nlm.nih.gov/pubmed/34540155
http://dx.doi.org/10.18502/ijm.v13i2.5981
_version_ 1783746741309276160
author Ahmadinejad, Zahra
Mokhtaryan, Maryam
Salami, Arezoo
Talebian, Monavar
Irajian, Hamideh
Ghiasvand, Fereshteh
author_facet Ahmadinejad, Zahra
Mokhtaryan, Maryam
Salami, Arezoo
Talebian, Monavar
Irajian, Hamideh
Ghiasvand, Fereshteh
author_sort Ahmadinejad, Zahra
collection PubMed
description BACKGROUND AND OBJECTIVES: Tuberculosis is one of the main reasons for mortality in liver transplant recipients. Since Iran is considered as a tuberculosis-endemic country, the present study aims to evaluate the outcome of latent tuberculosis infection in transplant recipients after liver transplantation. MATERIALS AND METHODS: The present analytical cross-sectional study was performed on transplanted patients in Imam Khomeini Complex Hospital in Tehran Iran from 2006 to 2016. All patients with positive tuberculin skin test were enrolled. Variables including demographic information, therapeutic and outcome data were gathered and analyzed. RESULTS: Among 675 transplant recipients, 100 patients had positive tuberculin skin test (14.8%). Sixty seven percent of recipients were men and the mean age was 72.67 ± 1.3 years. All patients’ received Isoniazid prophylaxis before transplantation. The mean duration of anti-tuberculosis prophylaxis before and after transplant were 2.7 ± 1.9 and 3.6 ± 5.5 months, respectively. Tuberculosis has not been occurred in none of these patients after a mean follow up time of 45.21 ± 3 months. During the study period, four subjects infected by Mycobacterium tuberculosis, while their skin test was negative before transplant. CONCLUSION: According to our study, tuberculin skin test is a reliable and sensitive test for diagnosis of latent tuberculosis in liver transplant candidates. Isoniazid prophylaxis is well tolerated in patients with end stage liver diseases and liver transplant recipients.
format Online
Article
Text
id pubmed-8408033
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-84080332021-09-16 Evaluation of latent tuberculosis infection in liver transplant recipients Ahmadinejad, Zahra Mokhtaryan, Maryam Salami, Arezoo Talebian, Monavar Irajian, Hamideh Ghiasvand, Fereshteh Iran J Microbiol Original Article BACKGROUND AND OBJECTIVES: Tuberculosis is one of the main reasons for mortality in liver transplant recipients. Since Iran is considered as a tuberculosis-endemic country, the present study aims to evaluate the outcome of latent tuberculosis infection in transplant recipients after liver transplantation. MATERIALS AND METHODS: The present analytical cross-sectional study was performed on transplanted patients in Imam Khomeini Complex Hospital in Tehran Iran from 2006 to 2016. All patients with positive tuberculin skin test were enrolled. Variables including demographic information, therapeutic and outcome data were gathered and analyzed. RESULTS: Among 675 transplant recipients, 100 patients had positive tuberculin skin test (14.8%). Sixty seven percent of recipients were men and the mean age was 72.67 ± 1.3 years. All patients’ received Isoniazid prophylaxis before transplantation. The mean duration of anti-tuberculosis prophylaxis before and after transplant were 2.7 ± 1.9 and 3.6 ± 5.5 months, respectively. Tuberculosis has not been occurred in none of these patients after a mean follow up time of 45.21 ± 3 months. During the study period, four subjects infected by Mycobacterium tuberculosis, while their skin test was negative before transplant. CONCLUSION: According to our study, tuberculin skin test is a reliable and sensitive test for diagnosis of latent tuberculosis in liver transplant candidates. Isoniazid prophylaxis is well tolerated in patients with end stage liver diseases and liver transplant recipients. Tehran University of Medical Sciences 2021-04 /pmc/articles/PMC8408033/ /pubmed/34540155 http://dx.doi.org/10.18502/ijm.v13i2.5981 Text en Copyright © 2021 The Authors. Published by Tehran University of Medical Sciences https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited.
spellingShingle Original Article
Ahmadinejad, Zahra
Mokhtaryan, Maryam
Salami, Arezoo
Talebian, Monavar
Irajian, Hamideh
Ghiasvand, Fereshteh
Evaluation of latent tuberculosis infection in liver transplant recipients
title Evaluation of latent tuberculosis infection in liver transplant recipients
title_full Evaluation of latent tuberculosis infection in liver transplant recipients
title_fullStr Evaluation of latent tuberculosis infection in liver transplant recipients
title_full_unstemmed Evaluation of latent tuberculosis infection in liver transplant recipients
title_short Evaluation of latent tuberculosis infection in liver transplant recipients
title_sort evaluation of latent tuberculosis infection in liver transplant recipients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408033/
https://www.ncbi.nlm.nih.gov/pubmed/34540155
http://dx.doi.org/10.18502/ijm.v13i2.5981
work_keys_str_mv AT ahmadinejadzahra evaluationoflatenttuberculosisinfectioninlivertransplantrecipients
AT mokhtaryanmaryam evaluationoflatenttuberculosisinfectioninlivertransplantrecipients
AT salamiarezoo evaluationoflatenttuberculosisinfectioninlivertransplantrecipients
AT talebianmonavar evaluationoflatenttuberculosisinfectioninlivertransplantrecipients
AT irajianhamideh evaluationoflatenttuberculosisinfectioninlivertransplantrecipients
AT ghiasvandfereshteh evaluationoflatenttuberculosisinfectioninlivertransplantrecipients